首页 > 最新文献

Current protocols最新文献

英文 中文
Preparation and Characterization of Alginate-Based Bioinks for Three-Dimensional Bioprinting of Cell-Laden Constructs 海藻酸盐基三维生物打印材料的制备与表征。
IF 2.2 Pub Date : 2025-12-28 DOI: 10.1002/cpz1.70290
Nuraina Anisa Dahlan, Farinaz Ketabat, Kathryn Avery, Xavier L. Tabil, Samira Khoz, Elise Altarriba, Neeraj Dhar, Xiongbiao Chen

Biomaterial-based bioinks are increasingly utilized in bioprinting to engineer three-dimensional (3D) constructs with living cells for tissue engineering and disease modeling. Among various bioinks explored, alginate-based formulations stand out due to their good biocompatibility, mild gelation conditions, tunable mechanical properties, and ease of crosslinking via divalent cations such as calcium. Despite their widespread use, standardized protocols for preparing alginate-based bioinks and characterizing bioprinted constructs have not been well documented. Our laboratory has developed and validated reproducible methods for preparing a variety of alginate-based bioinks and printing cell-laden constructs tailored for diverse applications. In this article, we present detailed step-by-step protocols covering bioink preparation and rheological characterization, extrusion-based bioprinting of cell-laden constructs, post-printing culture and co-culture techniques, printability assessment, and live/dead and immunofluorescence assays. These protocols serve as a standardized framework for the fabrication and characterization of 3D bioprinted alginate-based cell-laden constructs, thereby facilitating translational research in tissue engineering, disease modeling, and preclinical therapeutic development. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.

Basic Protocol 1: Bioink preparation

Basic Protocol 2: Bioink characterization using rheology

Basic Protocol 3: Scaffold design and bioprinting

Support Protocol: 3D-printing parameter determination

Basic Protocol 4: Printability and cell viability analyses, and immunofluorescence assay

生物材料为基础的生物墨水越来越多地用于生物打印工程的三维(3D)结构与活细胞的组织工程和疾病建模。在探索的各种生物墨水中,海藻酸盐基配方因其良好的生物相容性,温和的凝胶条件,可调节的机械性能以及易于通过二价阳离子(如钙)交联而脱颖而出。尽管它们被广泛使用,但制备海藻酸盐基生物墨水和表征生物打印结构的标准化方案尚未得到很好的记录。我们的实验室已经开发并验证了可重复的方法,用于制备各种海藻酸盐基生物墨水和打印适合各种应用的细胞负载结构。在本文中,我们介绍了详细的一步一步的方案,包括生物墨水的制备和流变特性,基于挤压的细胞负载构建的生物打印,打印后培养和共培养技术,可打印性评估,活/死和免疫荧光分析。这些方案可作为3D生物打印海藻酸盐细胞负载结构的制造和表征的标准化框架,从而促进组织工程、疾病建模和临床前治疗开发的转化研究。©2025作者。当前协议由Wiley期刊有限责任公司发布。基本协议1:生物墨水制备基本协议2:使用流变学的生物墨水表征基本协议3:支架设计和生物打印支持协议:3d打印参数确定基本协议4:可打印性和细胞活力分析,以及免疫荧光测定。
{"title":"Preparation and Characterization of Alginate-Based Bioinks for Three-Dimensional Bioprinting of Cell-Laden Constructs","authors":"Nuraina Anisa Dahlan,&nbsp;Farinaz Ketabat,&nbsp;Kathryn Avery,&nbsp;Xavier L. Tabil,&nbsp;Samira Khoz,&nbsp;Elise Altarriba,&nbsp;Neeraj Dhar,&nbsp;Xiongbiao Chen","doi":"10.1002/cpz1.70290","DOIUrl":"10.1002/cpz1.70290","url":null,"abstract":"<p>Biomaterial-based bioinks are increasingly utilized in bioprinting to engineer three-dimensional (3D) constructs with living cells for tissue engineering and disease modeling. Among various bioinks explored, alginate-based formulations stand out due to their good biocompatibility, mild gelation conditions, tunable mechanical properties, and ease of crosslinking via divalent cations such as calcium. Despite their widespread use, standardized protocols for preparing alginate-based bioinks and characterizing bioprinted constructs have not been well documented. Our laboratory has developed and validated reproducible methods for preparing a variety of alginate-based bioinks and printing cell-laden constructs tailored for diverse applications. In this article, we present detailed step-by-step protocols covering bioink preparation and rheological characterization, extrusion-based bioprinting of cell-laden constructs, post-printing culture and co-culture techniques, printability assessment, and live/dead and immunofluorescence assays. These protocols serve as a standardized framework for the fabrication and characterization of 3D bioprinted alginate-based cell-laden constructs, thereby facilitating translational research in tissue engineering, disease modeling, and preclinical therapeutic development. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Bioink preparation</p><p><b>Basic Protocol 2</b>: Bioink characterization using rheology</p><p><b>Basic Protocol 3</b>: Scaffold design and bioprinting</p><p><b>Support Protocol</b>: 3D-printing parameter determination</p><p><b>Basic Protocol 4</b>: Printability and cell viability analyses, and immunofluorescence assay</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://currentprotocols.onlinelibrary.wiley.com/doi/epdf/10.1002/cpz1.70290","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145851755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis of 4′-C-α-Aminoethoxy-2′-O-Methyl-5-Methyl- and 5-Propynyl-Uridine Phosphoramidites for Structurally Optimized Antisense Oligonucleotides 4′- c -α-氨基乙氧基-2′- o -甲基-5-甲基-和5-丙基尿苷磷酰胺的合成及其反义寡核苷酸结构优化
IF 2.2 Pub Date : 2025-12-26 DOI: 10.1002/cpz1.70292
Elsayed M. Mahmoud, Yoshihito Ueno
<p>Chemical modifications are fundamental to improving the physicochemical and biological performance of oligonucleotide (ON) therapeutics by enhancing their hybridization affinity, nuclease resistance, and metabolic stability. Among the various sugar modifications developed, 4′-carbon (4′-<i>C</i>) substitutions have attracted significant attention for their ability to reinforce the sugar-phosphate backbone while preserving the natural <i>C</i>3′-<i>endo</i> conformation and Watson-Crick base pairing. The 4′-<i>C</i>-α-aminoethoxy (4′AEo) framework, in particular, provides steric protection against nuclease degradation without impairing RNase H activity, making it a valuable scaffold for next-generation antisense oligonucleotides (ASOs). This article presents optimized and reproducible synthetic protocols for two novel 4′-<i>C</i>-modified uridine phosphoramidite building blocks, 4′AEo<sup>m</sup>U (4′-<i>C</i>-α-aminoethoxy-2′-<i>O</i>-methyl-5-methyluridine) and 4′AEo<sup>p</sup>U (4′-<i>C</i>-α-aminoethoxy-2′-<i>O</i>-methyl-5-(1-propynyl)uridine), both fully compatible with automated solid-phase oligonucleotide synthesis. The synthesis of 4′AEo<sup>m</sup>U begins with commercially available 2′-<i>O</i>-methyl-5-methyluridine, which undergoes iodination of the 5′-hydroxyl group, 4′,5′-reductive dehalogenation, and 3′-<i>O</i>-silyl protection, followed by 4′,5′-epoxidation and ZnCl<sub>2</sub>-mediated nucleophilic epoxide opening with <i>N</i>-trifluoroacetylaminoethanol to afford the α-configured product as the major isomer, as confirmed by NOESY NMR analysis. In the 4′AEo<sup>p</sup>U synthetic route, regioselective <i>O</i>-silyl deprotection of the 4′-C-α-aminoethoxy-2′-O-methyluridine derivative (compound <b>10</b>) is followed by 5-iodination and subsequent Sonogashira-Hagihara coupling to introduce the 5-propynyl substituent. The resulting intermediate then undergoes 5′-<i>O</i>-DMTr protection and phosphitylation to yield the desired phosphoramidite. Both protocols exhibit high stereochemical control, reproducibility, and efficiency, yielding analytically pure intermediates validated by TLC, NMR, and mass spectrometry. Compared with previously reported synthetic approaches relying on glycal or radical intermediates, these methods minimize reaction complexity, improve yields, and maintain compatibility with standard phosphoramidite chemistry. Collectively, the described synthetic routes provide a reliable and scalable platform for generating structurally defined 4′-<i>C</i>-modified uridine derivatives. The resulting phosphoramidites enable the construction of antisense oligonucleotides with enhanced duplex stability, nuclease resistance, and favorable pharmacological properties, thereby advancing the rational design of next-generation ON therapeutics with improved safety and efficacy. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Synthesis of 4′-C-α-aminoethoxy-2′-<i>O</i>
化学修饰是通过提高寡核苷酸(ON)治疗药物的杂交亲和力、核酸酶抗性和代谢稳定性来改善其物理化学和生物学性能的基础。在已开发的各种糖修饰中,4'-碳(4'-C)取代因其在保留天然C3'-末端构象和沃森-克里克碱基对的同时加强糖-磷酸主链的能力而引起了人们的极大关注。特别是4′-C-α-氨基乙氧基(4′aeo)框架,在不损害RNase H活性的情况下提供抗核酸酶降解的空间保护,使其成为下一代反义寡核苷酸(ASOs)的有价值的支架。本文提出了两种新型4′- c修饰的尿嘧啶磷酸基的优化合成方案,4′aeomu(4′- c -α-氨基乙氧基-2′- o -甲基-5-甲基尿嘧啶)和4′aeopu(4′- c -α-氨基乙氧基-2′- o -甲基-5-(1-丙基)尿嘧啶),两者均可完全兼容固相寡核苷酸自动合成。4' aeomu的合成始于市售的2'- o -甲基-5-甲基尿嘧啶,经过5'-羟基碘化,4',5'-还原脱卤和3'- o -硅基保护,然后4',5'-环氧化和zncl2介导的亲核环氧化物与n -三氟乙酰氨基乙醇开孔,得到α-构型产物,这是noesi NMR分析证实的主要异构体。在4′aeopu的合成路线中,对4′-C-α-氨基乙氧基-2′- o -甲基尿嘧啶衍生物(化合物10)进行区域选择性o -硅基脱保护,然后进行5-碘化,随后Sonogashira-Hagihara偶联以引入5-丙基取代基。然后产生的中间体经历5'-O-DMTr保护和磷酸化,以产生所需的酰胺磷。两种方案都具有高度的立体化学控制、再现性和效率,产生的分析纯中间体经TLC、NMR和质谱验证。与先前报道的依赖于糖基或自由基中间体的合成方法相比,这些方法最大限度地减少了反应的复杂性,提高了产率,并保持了与标准磷酸酰胺化学的相容性。总的来说,所描述的合成路线为生成结构上定义的4'- c修饰的尿嘧啶衍生物提供了可靠和可扩展的平台。由此产生的磷酰胺使得反义寡核苷酸的构建具有增强的双相稳定性、核酸酶抗性和良好的药理特性,从而促进了下一代ON治疗药物的合理设计,提高了安全性和有效性。©2025作者。Wiley期刊有限责任公司发表的现有方案:基本方案1:合成4'- α-氨基乙氧基-2'- o -甲基-5-甲基尿嘧啶磷酸(4AEomU)(9)基本方案2:合成4'- c -α-氨基乙氧基-2'- o -甲基-5-(1-丙基)尿嘧啶磷酸(4AEopU)(15)。
{"title":"Synthesis of 4′-C-α-Aminoethoxy-2′-O-Methyl-5-Methyl- and 5-Propynyl-Uridine Phosphoramidites for Structurally Optimized Antisense Oligonucleotides","authors":"Elsayed M. Mahmoud,&nbsp;Yoshihito Ueno","doi":"10.1002/cpz1.70292","DOIUrl":"10.1002/cpz1.70292","url":null,"abstract":"&lt;p&gt;Chemical modifications are fundamental to improving the physicochemical and biological performance of oligonucleotide (ON) therapeutics by enhancing their hybridization affinity, nuclease resistance, and metabolic stability. Among the various sugar modifications developed, 4′-carbon (4′-&lt;i&gt;C&lt;/i&gt;) substitutions have attracted significant attention for their ability to reinforce the sugar-phosphate backbone while preserving the natural &lt;i&gt;C&lt;/i&gt;3′-&lt;i&gt;endo&lt;/i&gt; conformation and Watson-Crick base pairing. The 4′-&lt;i&gt;C&lt;/i&gt;-α-aminoethoxy (4′AEo) framework, in particular, provides steric protection against nuclease degradation without impairing RNase H activity, making it a valuable scaffold for next-generation antisense oligonucleotides (ASOs). This article presents optimized and reproducible synthetic protocols for two novel 4′-&lt;i&gt;C&lt;/i&gt;-modified uridine phosphoramidite building blocks, 4′AEo&lt;sup&gt;m&lt;/sup&gt;U (4′-&lt;i&gt;C&lt;/i&gt;-α-aminoethoxy-2′-&lt;i&gt;O&lt;/i&gt;-methyl-5-methyluridine) and 4′AEo&lt;sup&gt;p&lt;/sup&gt;U (4′-&lt;i&gt;C&lt;/i&gt;-α-aminoethoxy-2′-&lt;i&gt;O&lt;/i&gt;-methyl-5-(1-propynyl)uridine), both fully compatible with automated solid-phase oligonucleotide synthesis. The synthesis of 4′AEo&lt;sup&gt;m&lt;/sup&gt;U begins with commercially available 2′-&lt;i&gt;O&lt;/i&gt;-methyl-5-methyluridine, which undergoes iodination of the 5′-hydroxyl group, 4′,5′-reductive dehalogenation, and 3′-&lt;i&gt;O&lt;/i&gt;-silyl protection, followed by 4′,5′-epoxidation and ZnCl&lt;sub&gt;2&lt;/sub&gt;-mediated nucleophilic epoxide opening with &lt;i&gt;N&lt;/i&gt;-trifluoroacetylaminoethanol to afford the α-configured product as the major isomer, as confirmed by NOESY NMR analysis. In the 4′AEo&lt;sup&gt;p&lt;/sup&gt;U synthetic route, regioselective &lt;i&gt;O&lt;/i&gt;-silyl deprotection of the 4′-C-α-aminoethoxy-2′-O-methyluridine derivative (compound &lt;b&gt;10&lt;/b&gt;) is followed by 5-iodination and subsequent Sonogashira-Hagihara coupling to introduce the 5-propynyl substituent. The resulting intermediate then undergoes 5′-&lt;i&gt;O&lt;/i&gt;-DMTr protection and phosphitylation to yield the desired phosphoramidite. Both protocols exhibit high stereochemical control, reproducibility, and efficiency, yielding analytically pure intermediates validated by TLC, NMR, and mass spectrometry. Compared with previously reported synthetic approaches relying on glycal or radical intermediates, these methods minimize reaction complexity, improve yields, and maintain compatibility with standard phosphoramidite chemistry. Collectively, the described synthetic routes provide a reliable and scalable platform for generating structurally defined 4′-&lt;i&gt;C&lt;/i&gt;-modified uridine derivatives. The resulting phosphoramidites enable the construction of antisense oligonucleotides with enhanced duplex stability, nuclease resistance, and favorable pharmacological properties, thereby advancing the rational design of next-generation ON therapeutics with improved safety and efficacy. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Basic Protocol 1&lt;/b&gt;: Synthesis of 4′-C-α-aminoethoxy-2′-&lt;i&gt;O&lt;/i&gt;","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12742032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fermentation and Purification of Recombinant Human Type III Collagen Expressed in Escherichia coli 大肠杆菌表达重组人ⅲ型胶原蛋白的发酵与纯化。
IF 2.2 Pub Date : 2025-12-26 DOI: 10.1002/cpz1.70284
Jinwei Zhai, Wansen Tan, Lei Ji, Jingjun Hong

This article mainly describes a fermentation and purification method for expressing recombinant collagen protein in Escherichia coli. The method comprises constructing engineered bacteria expressing human type III collagen and adopting a strategy of feeding in batches for high-density fermentation. The rapid proliferation of bacterial cells is promoted at 37°C, and then the culture is inoculated into a fermentation tank with different carbon sources for growth. When glycerol is used as the main carbon source, the yield of recombinant collagen protein can reach 0.25 to 0.40 g/L. The method allows exploration of the differences in recombinant collagen production with different carbon sources in order to identify the most suitable fermentation medium component. The human type III collagen produced by the method has the typical structure of collagen, with high cell adhesion and the stability of tissue structure. Therefore, it can be used as the raw material for various collagen products, especially facial fillers, dressings, freeze-dried fibers, and gels. © 2025 Wiley Periodicals LLC.

Basic Protocol: Fermentation and purification of recombinant human type III collagen expressed in Escherichia coli

本文主要介绍了一种在大肠杆菌中表达重组胶原蛋白的发酵纯化方法。该方法包括构建表达人ⅲ型胶原蛋白的工程菌,采用分批饲养的策略进行高密度发酵。在37℃下促进细菌细胞的快速增殖,然后将培养物接种到不同碳源的发酵罐中进行生长。以甘油为主要碳源时,重组胶原蛋白的产率可达0.25 ~ 0.40 g/L。该方法允许探索不同碳源在重组胶原蛋白生产中的差异,以确定最合适的发酵培养基成分。该方法制备的人ⅲ型胶原蛋白具有典型的胶原蛋白结构,具有较高的细胞粘附性和组织结构的稳定性。因此,它可以作为各种胶原蛋白制品的原料,特别是面部填充剂、敷料、冻干纤维、凝胶。©2025 Wiley期刊有限责任公司。基本方案:大肠杆菌表达的重组人III型胶原的发酵和纯化。
{"title":"Fermentation and Purification of Recombinant Human Type III Collagen Expressed in Escherichia coli","authors":"Jinwei Zhai,&nbsp;Wansen Tan,&nbsp;Lei Ji,&nbsp;Jingjun Hong","doi":"10.1002/cpz1.70284","DOIUrl":"10.1002/cpz1.70284","url":null,"abstract":"<p>This article mainly describes a fermentation and purification method for expressing recombinant collagen protein in <i>Escherichia coli</i>. The method comprises constructing engineered bacteria expressing human type III collagen and adopting a strategy of feeding in batches for high-density fermentation. The rapid proliferation of bacterial cells is promoted at 37°C, and then the culture is inoculated into a fermentation tank with different carbon sources for growth. When glycerol is used as the main carbon source, the yield of recombinant collagen protein can reach 0.25 to 0.40 g/L. The method allows exploration of the differences in recombinant collagen production with different carbon sources in order to identify the most suitable fermentation medium component. The human type III collagen produced by the method has the typical structure of collagen, with high cell adhesion and the stability of tissue structure. Therefore, it can be used as the raw material for various collagen products, especially facial fillers, dressings, freeze-dried fibers, and gels. © 2025 Wiley Periodicals LLC.</p><p><b>Basic Protocol</b>: Fermentation and purification of recombinant human type III collagen expressed in <i>Escherichia coli</i></p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analyzing Large Connectome Graphs With BossDB Network Tools 用BossDB网络工具分析大型连接图。
IF 2.2 Pub Date : 2025-12-26 DOI: 10.1002/cpz1.70273
Jordan K. Matelsky, Hannah Martinez, Daniel Xenes, Michael Robinette, Akshita Panigrahi, Brock Wester

Modern connectomics enables large-scale, comparative network neuroscience across individuals, species, development, and evolution. The field now regularly produces extensive maps of neural connectivity exceeding hundreds of millions of synapses in continuous volumes. When connectomes are deposited in central archives such as BossDB with standardized metadata, researchers can pose previously intractable questions about neuronal networks. Here, we present step-by-step protocols for connectome dataset discovery and access, scalable graph construction and analysis, and reproducible comparative connectomics using BossDB, Motif Studio, DotMotif, Neuroglancer, neuPrint, and Python-based workflows. These protocols target bench neuroscientists and computational biologists and emphasize replicability, cloud-friendly options, and publication-quality visualization. © 2025 Wiley Periodicals LLC.

Basic Protocol 1: Discovering connectome datasets and computing summary statistics with BossDB and Motif Studio

Basic Protocol 2: Writing queries with DotMotif

Basic Protocol 3: Querying known network motifs locally with DotMotif

Support Protocol 1: Provisioning ad hoc graph databases for large-scale graph analysis

Support Protocol 2: Querying structures and systems in the cloud with neuPrint

Basic Protocol 4: Viewing anatomical motif features with BossDB and Neuroglancer

现代连接组学使跨个体、物种、发育和进化的大规模、比较网络神经科学成为可能。这个领域现在经常产生大量的神经连通性图,超过数亿个连续的突触。当连接体被储存在BossDB等具有标准化元数据的中央档案中时,研究人员可以提出以前难以解决的关于神经网络的问题。在这里,我们介绍了使用BossDB、Motif Studio、DotMotif、Neuroglancer、neuPrint和基于python的工作流程的连接组数据发现和访问、可扩展的图构建和分析以及可重复的比较连接组的逐步协议。这些协议的目标是神经科学家和计算生物学家,并强调可复制性、云友好选项和出版质量的可视化。©2025 Wiley期刊有限责任公司基本协议1:发现连接组数据集和计算汇总统计与BossDB和Motif Studio基本协议2:用DotMotif基本协议编写查询3:用DotMotif支持协议查询本地已知网络Motif 1:为大规模图形分析提供临时图形数据库支持协议2:在云中查询结构和系统与neuPrint基本协议4:用BossDB和Neuroglancer观察解剖基序特征。
{"title":"Analyzing Large Connectome Graphs With BossDB Network Tools","authors":"Jordan K. Matelsky,&nbsp;Hannah Martinez,&nbsp;Daniel Xenes,&nbsp;Michael Robinette,&nbsp;Akshita Panigrahi,&nbsp;Brock Wester","doi":"10.1002/cpz1.70273","DOIUrl":"10.1002/cpz1.70273","url":null,"abstract":"<p>Modern connectomics enables large-scale, comparative network neuroscience across individuals, species, development, and evolution. The field now regularly produces extensive maps of neural connectivity exceeding hundreds of millions of synapses in continuous volumes. When connectomes are deposited in central archives such as BossDB with standardized metadata, researchers can pose previously intractable questions about neuronal networks. Here, we present step-by-step protocols for connectome dataset discovery and access, scalable graph construction and analysis, and reproducible comparative connectomics using BossDB, Motif Studio, DotMotif, Neuroglancer, neuPrint, and Python-based workflows. These protocols target bench neuroscientists and computational biologists and emphasize replicability, cloud-friendly options, and publication-quality visualization. © 2025 Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Discovering connectome datasets and computing summary statistics with BossDB and Motif Studio</p><p><b>Basic Protocol 2</b>: Writing queries with DotMotif</p><p><b>Basic Protocol 3</b>: Querying known network motifs locally with DotMotif</p><p><b>Support Protocol 1</b>: Provisioning ad hoc graph databases for large-scale graph analysis</p><p><b>Support Protocol 2</b>: Querying structures and systems in the cloud with neuPrint</p><p><b>Basic Protocol 4</b>: Viewing anatomical motif features with BossDB and Neuroglancer</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waste Not, Want Not: How to Make Your Data Futureproof Through Good Data Sharing Practices 不浪费,不需要:如何通过良好的数据共享实践使您的数据经得起未来的考验。
IF 2.2 Pub Date : 2025-12-22 DOI: 10.1002/cpz1.70283
Nina Vitlov, Miro Vuković, Nensi Bralić, Ana Marušić

Scientific progress relies on the generation, validation, and reuse of research data, yet standard practices and cultural, legal, and technological challenges have long limited data sharing. In the 21st century, growing volumes of data, higher transparency requirements, and concerns about reproducibility have pushed research data management to the forefront. This manuscript brings together three perspectives to provide an extensive overview of data sharing: theoretical foundations, ethical and normative frameworks, and practical implementation. First, it discusses the way research data differs across fields and formats, the distinction between primary and secondary data, and how metadata helps ensure data can be reused. It emphasizes how open data fosters transparency, reproducibility, accountability, and innovation, while also acknowledging that research data has historically been viewed as private intellectual property. Second, it explores the emergence of principles and ethical standards designed to enhance data quality and promote responsible use. Documentation standards, data management plans, and sharing of code and workflows have helped the FAIR (Findability, Accessibility, Interoperability, and Reusability) principles become a cornerstone for data sharing. Regulatory frameworks, such as the General Data Protection Regulation (GDPR) and California Consumer Privacy Act (CCPA), as well as mechanisms such as de-identification and Data Trusts, address legal and ethical issues, including privacy protection, licensing, and data governance. Finally, the third major topic discusses how these principles are implemented through infrastructure, incentives, and new technologies. It addresses the significance of cultural change and recognition systems, the impact of policies by journals and funders, and the role of repositories in preservation and interoperability. It also emphasizes the emergence of novel trends, such as artificial intelligence–driven metadata generation, blockchain-based provenance, executable workflows, and privacy-preserving computation, all of which are redefining the concept of responsible and scalable data sharing. By connecting conceptual, ethical, and practical dimensions, the manuscript outlines both current challenges and realistic pathways toward transparent, collaborative, and future-oriented research. © 2025 Wiley Periodicals LLC.

科学进步依赖于研究数据的生成、验证和重用,然而标准实践以及文化、法律和技术挑战长期以来限制了数据共享。在21世纪,不断增长的数据量、更高的透明度要求以及对可重复性的关注将研究数据管理推向了最前沿。该手稿汇集了三个观点,提供了数据共享的广泛概述:理论基础,道德和规范框架,以及实际实施。首先,它讨论了研究数据在不同领域和格式之间的差异,主要数据和次要数据之间的区别,以及元数据如何帮助确保数据可以重用。它强调开放数据如何促进透明度、可重复性、问责制和创新,同时也承认研究数据历来被视为私有知识产权。其次,它探讨了旨在提高数据质量和促进负责任使用的原则和道德标准的出现。文档标准、数据管理计划以及代码和工作流的共享已经帮助FAIR(可查找性、可访问性、互操作性和可重用性)原则成为数据共享的基石。监管框架,如《通用数据保护条例》(GDPR)和《加州消费者隐私法》(CCPA),以及去识别和数据信托等机制,解决了法律和道德问题,包括隐私保护、许可和数据治理。最后,第三个主要主题讨论了如何通过基础设施、激励措施和新技术来实施这些原则。它讨论了文化变革和识别系统的重要性,期刊和资助者政策的影响,以及知识库在保存和互操作性中的作用。它还强调了新趋势的出现,例如人工智能驱动的元数据生成、基于区块链的来源、可执行工作流程和隐私保护计算,所有这些都在重新定义负责任和可扩展数据共享的概念。通过连接概念、伦理和实践维度,该手稿概述了当前的挑战和实现透明、协作和面向未来的研究的现实途径。©2025 Wiley期刊有限责任公司
{"title":"Waste Not, Want Not: How to Make Your Data Futureproof Through Good Data Sharing Practices","authors":"Nina Vitlov,&nbsp;Miro Vuković,&nbsp;Nensi Bralić,&nbsp;Ana Marušić","doi":"10.1002/cpz1.70283","DOIUrl":"10.1002/cpz1.70283","url":null,"abstract":"<p>Scientific progress relies on the generation, validation, and reuse of research data, yet standard practices and cultural, legal, and technological challenges have long limited data sharing. In the 21<sup>st</sup> century, growing volumes of data, higher transparency requirements, and concerns about reproducibility have pushed research data management to the forefront. This manuscript brings together three perspectives to provide an extensive overview of data sharing: theoretical foundations, ethical and normative frameworks, and practical implementation. First, it discusses the way research data differs across fields and formats, the distinction between primary and secondary data, and how metadata helps ensure data can be reused. It emphasizes how open data fosters transparency, reproducibility, accountability, and innovation, while also acknowledging that research data has historically been viewed as private intellectual property. Second, it explores the emergence of principles and ethical standards designed to enhance data quality and promote responsible use. Documentation standards, data management plans, and sharing of code and workflows have helped the FAIR (Findability, Accessibility, Interoperability, and Reusability) principles become a cornerstone for data sharing. Regulatory frameworks, such as the General Data Protection Regulation (GDPR) and California Consumer Privacy Act (CCPA), as well as mechanisms such as de-identification and Data Trusts, address legal and ethical issues, including privacy protection, licensing, and data governance. Finally, the third major topic discusses how these principles are implemented through infrastructure, incentives, and new technologies. It addresses the significance of cultural change and recognition systems, the impact of policies by journals and funders, and the role of repositories in preservation and interoperability. It also emphasizes the emergence of novel trends, such as artificial intelligence–driven metadata generation, blockchain-based provenance, executable workflows, and privacy-preserving computation, all of which are redefining the concept of responsible and scalable data sharing. By connecting conceptual, ethical, and practical dimensions, the manuscript outlines both current challenges and realistic pathways toward transparent, collaborative, and future-oriented research. © 2025 Wiley Periodicals LLC.</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis of Triphosphate Nucleoside Prodrugs: γ-ProTriPs 三磷酸核苷前药γ-ProTriPs的合成。
IF 2.2 Pub Date : 2025-12-22 DOI: 10.1002/cpz1.70291
Camille Tisnerat, Fabrizio Pertusati, Michaela Serpi

Although monophosphate nucleoside prodrug approaches have been extensively investigated, leading to the development of several key antiviral and anticancer drugs, less attention has been given to the design of triphosphate prodrugs for the delivery of triphosphorylated nucleotide analogues. Expanding on this strategy, we report here an efficient synthetic methodology for preparing nucleoside triphosphate prodrugs, in which the γ-phosphate of a nucleotide is masked with an amino acid ester and an aryloxy group (γ-ProTriP). This approach aims to achieve the direct intracellular release of the triphosphate nucleotide active species, circumventing metabolic bottlenecks and potential toxicity that are often associated with the accumulation of nucleoside analogues and/or their mono- and diphosphate species. This article outlines the synthetic strategy for preparing γ-ProTriP derivatives using either microwave-accelerated synthesis or conventional heating methods. The approach is exemplified by the preparation of a clofarabine γ-ProTriP, which emerges as a promising alternative to traditional monophosphate prodrug strategies. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.

Basic Protocol: Preparation of triphosphate aryloxy phosphoramidate of adenosine, uridine, and clofarabine with microwave heating

Alternate Protocol: Preparation of triphosphate aryloxy phosphoramidate of adenosine with conventional heating

Support Protocol 1: Cation exchange of UDP disodium salt to UDP di(triethylammonium) salt

Support Protocol 2: Synthesis of di(triethylammonium) salt of clofarabine 5′-diphosphate

Support Protocol 3: Synthesis of pentafluorophenyl phosphorylating reagents

尽管单磷酸核苷前药方法已被广泛研究,导致了几种关键抗病毒和抗癌药物的开发,但用于递送三磷酸化核苷酸类似物的三磷酸前药的设计却很少受到关注。在此策略的基础上,我们报告了一种制备核苷三磷酸前药的有效合成方法,其中核苷酸的γ-磷酸被氨基酸酯和芳氧基(γ-ProTriP)掩盖。该方法旨在实现三磷酸核苷酸活性物质的细胞内直接释放,绕过代谢瓶颈和潜在毒性,这些代谢瓶颈和潜在毒性通常与核苷类似物和/或其单磷酸和二磷酸物质的积累有关。本文概述了利用微波加速合成或传统加热方法制备γ-ProTriP衍生物的合成策略。该方法的例子是制备氯法拉滨γ-ProTriP,它成为传统单磷酸盐前药策略的有前途的替代品。©2025作者。Wiley期刊有限责任公司发表的现有方案。基本方案:用微波加热制备三磷酸芳基磷酸腺苷、尿苷和氯法拉滨备用方案:用常规加热制备三磷酸芳基磷酸腺苷支持方案1:UDP二钠盐阳离子交换到UDP二(三乙基铵)盐支持方案2:氯法拉滨二(三乙基铵)盐的合成支持方案3:五氟苯基磷酸化试剂的合成。
{"title":"Synthesis of Triphosphate Nucleoside Prodrugs: γ-ProTriPs","authors":"Camille Tisnerat,&nbsp;Fabrizio Pertusati,&nbsp;Michaela Serpi","doi":"10.1002/cpz1.70291","DOIUrl":"10.1002/cpz1.70291","url":null,"abstract":"<p>Although monophosphate nucleoside prodrug approaches have been extensively investigated, leading to the development of several key antiviral and anticancer drugs, less attention has been given to the design of triphosphate prodrugs for the delivery of triphosphorylated nucleotide analogues. Expanding on this strategy, we report here an efficient synthetic methodology for preparing nucleoside triphosphate prodrugs, in which the γ-phosphate of a nucleotide is masked with an amino acid ester and an aryloxy group (γ-ProTriP). This approach aims to achieve the direct intracellular release of the triphosphate nucleotide active species, circumventing metabolic bottlenecks and potential toxicity that are often associated with the accumulation of nucleoside analogues and/or their mono- and diphosphate species. This article outlines the synthetic strategy for preparing γ-ProTriP derivatives using either microwave-accelerated synthesis or conventional heating methods. The approach is exemplified by the preparation of a clofarabine γ-ProTriP, which emerges as a promising alternative to traditional monophosphate prodrug strategies. © 2025 The Author(s). <i>Current Protocols</i> published by Wiley Periodicals LLC.</p><p><b>Basic Protocol</b>: Preparation of triphosphate aryloxy phosphoramidate of adenosine, uridine, and clofarabine with microwave heating</p><p><b>Alternate Protocol</b>: Preparation of triphosphate aryloxy phosphoramidate of adenosine with conventional heating</p><p><b>Support Protocol 1</b>: Cation exchange of UDP disodium salt to UDP di(triethylammonium) salt</p><p><b>Support Protocol 2</b>: Synthesis of di(triethylammonium) salt of clofarabine 5′-diphosphate</p><p><b>Support Protocol 3</b>: Synthesis of pentafluorophenyl phosphorylating reagents</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12720395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vessel-on-a-Chip to Study Vascular Endothelial Inflammation 血管芯片研究血管内皮炎症。
IF 2.2 Pub Date : 2025-12-18 DOI: 10.1002/cpz1.70281
Svitlana M. Palii, Anastasiia Voytovych, Nadiya Muzyka, Nuria Chantada, Pablo J. Sáez, Ezequiel Álvarez, Oksana Shevchuk

The complex network of blood vessels plays a key role in transporting oxygen and nutrients and maintaining homeostasis in the human body. The inner walls of all blood and lymphatic vessels are lined by the endothelium, a monolayer of endothelial cells (ECs) oriented along the direction of blood flow. ECs play a pivotal role in vascular homeostasis, including regulating vascular tone, delivering oxygen and nutrients, modulating pro-inflammatory molecules and pro-inflammatory immune responses, and performing other vital functions. Therefore, the study of EC biology and vascular responses is key for a deeper understanding of vascular biology and the development of new therapeutics. Most studies in vivo and in vitro present technical challenges, either complexity or oversimplification, respectively, which slow down advances in the field. Therefore, 3D models and microfluidics offer a complementary alternative that integrates shapes similar to those observed in vivo, with the advantages of an in vitro system. Here, we present a robust and reproducible vessel-on-a-chip (VOC) composed of an EC monolayer and a microvascular microenvironment maintained by a peristaltic pump to ensure continuous media circulation and physiological levels of shear stress. In addition, we validated this model for in vitro studies of vascular inflammation by monitoring EC status. We observed cellular alignment after shear stress exposure, increased E-selectin expression, and TNF-induced morphological changes in ECs. This new VOC is a promising approach to studying EC mechanobiology and inflammation and opens new avenues for its versatile use in vascular biology, inflammation, and immune and cancer cell migration in a controlled, scalable manner. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.

Basic Protocol 1: 3D Vessel Formation within a microfluidic organ-on-a-chip system

Basic Protocol 2: Evaluation of shear stress

Basic Protocol 3: Evaluation of inflammation

复杂的血管网络在输送氧气和营养物质以及维持体内平衡方面起着关键作用。所有的血管和淋巴管的内壁都由内皮细胞(内皮细胞)组成,内皮细胞是沿血流方向排列的单层细胞。内皮细胞在血管稳态中起着关键作用,包括调节血管张力,输送氧气和营养物质,调节促炎分子和促炎免疫反应,以及执行其他重要功能。因此,研究EC生物学和血管反应是深入了解血管生物学和开发新疗法的关键。大多数体内和体外研究都存在技术挑战,要么过于复杂,要么过于简化,这减慢了该领域的进展。因此,3D模型和微流体提供了一种互补的替代方案,集成了与体内观察到的形状相似的形状,具有体外系统的优点。在这里,我们提出了一个强大的和可复制的血管芯片(VOC),由EC单层和由蠕动泵维持的微血管微环境组成,以确保连续的介质循环和生理水平的剪切应力。此外,我们通过监测EC状态验证了该模型用于血管炎症的体外研究。我们观察到剪切应力暴露后的细胞排列,e -选择素表达增加,以及tnf诱导的内皮细胞形态学变化。这种新的挥发性有机化合物是研究EC机械生物学和炎症的一种很有前途的方法,并为其在血管生物学、炎症、免疫和癌细胞迁移中的广泛应用开辟了新的途径。©2025作者。当前协议由Wiley期刊有限责任公司发布。基本协议1:微流控器官芯片系统内的3D血管形成基本协议2:剪切应力评估基本协议3:炎症评估。
{"title":"Vessel-on-a-Chip to Study Vascular Endothelial Inflammation","authors":"Svitlana M. Palii,&nbsp;Anastasiia Voytovych,&nbsp;Nadiya Muzyka,&nbsp;Nuria Chantada,&nbsp;Pablo J. Sáez,&nbsp;Ezequiel Álvarez,&nbsp;Oksana Shevchuk","doi":"10.1002/cpz1.70281","DOIUrl":"10.1002/cpz1.70281","url":null,"abstract":"<p>The complex network of blood vessels plays a key role in transporting oxygen and nutrients and maintaining homeostasis in the human body. The inner walls of all blood and lymphatic vessels are lined by the endothelium, a monolayer of endothelial cells (ECs) oriented along the direction of blood flow. ECs play a pivotal role in vascular homeostasis, including regulating vascular tone, delivering oxygen and nutrients, modulating pro-inflammatory molecules and pro-inflammatory immune responses, and performing other vital functions. Therefore, the study of EC biology and vascular responses is key for a deeper understanding of vascular biology and the development of new therapeutics. Most studies <i>in vivo</i> and <i>in vitro</i> present technical challenges, either complexity or oversimplification, respectively, which slow down advances in the field. Therefore, 3D models and microfluidics offer a complementary alternative that integrates shapes similar to those observed <i>in vivo</i>, with the advantages of an <i>in vitro</i> system. Here, we present a robust and reproducible vessel-on-a-chip (VOC) composed of an EC monolayer and a microvascular microenvironment maintained by a peristaltic pump to ensure continuous media circulation and physiological levels of shear stress. In addition, we validated this model for <i>in vitro</i> studies of vascular inflammation by monitoring EC status. We observed cellular alignment after shear stress exposure, increased E-selectin expression, and TNF-induced morphological changes in ECs. This new VOC is a promising approach to studying EC mechanobiology and inflammation and opens new avenues for its versatile use in vascular biology, inflammation, and immune and cancer cell migration in a controlled, scalable manner. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: 3D Vessel Formation within a microfluidic organ-on-a-chip system</p><p><b>Basic Protocol 2</b>: Evaluation of shear stress</p><p><b>Basic Protocol 3</b>: Evaluation of inflammation</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemoenzymatic Synthesis and Purification of Bioorthogonally Tagged UDP-GlcNAc and UDP-GalNAc Analogues 生物正交标记的UDP-GlcNAc和UDP-GalNAc类似物的化学酶合成和纯化。
IF 2.2 Pub Date : 2025-12-17 DOI: 10.1002/cpz1.70277
Ganka Bineva-Todd, Benjamin Schumann

Nucleotide-sugar donors containing bioorthogonal moieties are important tools to study cellular glycosylation. Typically, the acetamide moiety in N-acetylhexosamines such as GlcNAc and GalNAc is replaced by an acylamide with a clickable tag and converted to the corresponding uridine diphosphate analogue. These probes can then be tested for acceptance by glycosyltransferase enzymes in vitro. Lengthy procedures in synthetic chemistry currently limit the availability of bioorthogonal uridine diphosphate (UDP)-sugar analogues. Chemoenzymatic synthesis has proven to be a powerful and effective alternative, and multiple approaches have been published to date. In this protocol, we describe a streamlined method for the generation of bioorthogonal UDP-GlcNAc and UDP-GalNAc analogues. We describe the chemical modification of D-glucosamine and D-galactosamine to incorporate bioorthogonal acylamides, the subsequent one-pot multienzyme conversion to the corresponding UDP-sugar analogues, and reproducible purification. Our approach features the bacterial kinase NahK and human pyrophosphorylase AGX1 as well as a recombinantly expressed AGX1 variant with an expanded substrate profile. The approach further features an inorganic pyrophosphatase and an alkaline phosphatase to improve enzymatic turnover and aid the purification process, respectively. The use of biosynthetic enzymes with substrate promiscuity extends the scope of bioorthogonal nucleotide-sugar analogue structures to aid efforts in chemical glycobiology. © 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC.

Basic Protocol 1: Chemical synthesis of bioorthogonally tagged acylamide analogues of D-GlcNAc and D-GalNAc

Alternate Protocol 1: Chemical synthesis of bioorthogonally tagged acylamide analogues of D-GlcNAc and D-GalNAc from a protected GlcNH2 or GalNH2 precursor

Basic Protocol 2: Conversion of D-GlcNAc or D-GalNAc analogues to UDP-sugars using analytical- (reaction scouting) and preparative-scale enzymatic synthesis and purification

含有生物正交片段的核苷酸糖供体是研究细胞糖基化的重要工具。通常,n -乙酰基己糖(如GlcNAc和GalNAc)中的乙酰胺部分被带有可点击标签的丙烯酰胺取代,并转化为相应的尿苷二磷酸类似物。这些探针可以在体外被糖基转移酶接受。目前合成化学中冗长的程序限制了生物正交尿苷二磷酸(UDP)糖类似物的可用性。化学酶合成已被证明是一种强大而有效的替代方法,迄今为止已发表了多种方法。在本协议中,我们描述了一种简化的方法来生成生物正交的UDP-GlcNAc和UDP-GalNAc类似物。我们描述了d -氨基葡萄糖和d -半乳糖胺的化学修饰,以加入生物正交酰基酰胺,随后的一锅多酶转化为相应的udp -糖类似物,并可重复纯化。我们的方法具有细菌激酶NahK和人类焦磷酸化酶AGX1以及具有扩展底物谱的重组表达AGX1变体。该方法进一步具有无机焦磷酸酶和碱性磷酸酶,分别改善酶的周转和帮助纯化过程。具有底物混杂性的生物合成酶的使用扩展了生物正交核苷酸-糖类似物结构的范围,以帮助化学糖生物学的努力。©2025作者。由Wiley Periodicals LLC发表的当前方案:基本方案1:用受保护的GlcNH2或GalNH2前体化学合成生物正交标记的D-GlcNAc和D-GalNAc的丙烯酰胺类似物。基本方案2:利用分析(反应探测)和制备规模的酶合成和纯化将D-GlcNAc或D-GalNAc类似物转化为udp糖。
{"title":"Chemoenzymatic Synthesis and Purification of Bioorthogonally Tagged UDP-GlcNAc and UDP-GalNAc Analogues","authors":"Ganka Bineva-Todd,&nbsp;Benjamin Schumann","doi":"10.1002/cpz1.70277","DOIUrl":"10.1002/cpz1.70277","url":null,"abstract":"<p>Nucleotide-sugar donors containing bioorthogonal moieties are important tools to study cellular glycosylation. Typically, the acetamide moiety in <i>N</i>-acetylhexosamines such as GlcNAc and GalNAc is replaced by an acylamide with a clickable tag and converted to the corresponding uridine diphosphate analogue. These probes can then be tested for acceptance by glycosyltransferase enzymes <i>in vitro</i>. Lengthy procedures in synthetic chemistry currently limit the availability of bioorthogonal uridine diphosphate (UDP)-sugar analogues. Chemoenzymatic synthesis has proven to be a powerful and effective alternative, and multiple approaches have been published to date. In this protocol, we describe a streamlined method for the generation of bioorthogonal UDP-GlcNAc and UDP-GalNAc analogues. We describe the chemical modification of <span>D</span>-glucosamine and D-galactosamine to incorporate bioorthogonal acylamides, the subsequent one-pot multienzyme conversion to the corresponding UDP-sugar analogues, and reproducible purification. Our approach features the bacterial kinase NahK and human pyrophosphorylase AGX1 as well as a recombinantly expressed AGX1 variant with an expanded substrate profile. The approach further features an inorganic pyrophosphatase and an alkaline phosphatase to improve enzymatic turnover and aid the purification process, respectively. The use of biosynthetic enzymes with substrate promiscuity extends the scope of bioorthogonal nucleotide-sugar analogue structures to aid efforts in chemical glycobiology. © 2025 The Author(s). <i>Current Protocols</i> published by Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: Chemical synthesis of bioorthogonally tagged acylamide analogues of D-GlcNAc and D-GalNAc</p><p><b>Alternate Protocol 1</b>: Chemical synthesis of bioorthogonally tagged acylamide analogues of D-GlcNAc and D-GalNAc from a protected GlcNH<sub>2</sub> or GalNH<sub>2</sub> precursor</p><p><b>Basic Protocol 2</b>: Conversion of D-GlcNAc or D-GalNAc analogues to UDP-sugars using analytical- (reaction scouting) and preparative-scale enzymatic synthesis and purification</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12710852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145770316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dataset Readiness Assessment for Training (DRAFT): A Protocol for Auditing High-Dimensional Biological Data 培训数据集准备评估(草案):审计高维生物数据的协议。
IF 2.2 Pub Date : 2025-12-16 DOI: 10.1002/cpz1.70285
Guillaume Guerard, Sonia Djebali

This protocol details Dataset Readiness Assessment for Training (DRAFT), a systematic method for determining if a high-dimensional biological dataset is suitable for developing reliable and equitable machine learning models. Standard model validation often fails to detect when performance is driven by spurious correlations within the dataset, leading to irreproducible findings. DRAFT provides a step-by-step methodology to perform a multiaxis assessment of a dataset's integrity before extensive modeling begins. The assessment comprises three basic protocols to probe the dataset's characteristics: (1) evaluating its potential for generalization by testing baseline model performance and stability under rigorous cross-validation; (2) auditing for inherent biases by analyzing model performance and calibration across demographic subgroups; and (3) measuring its capacity for scientific utility by assessing the stability of predictive features. The Cancer Genome Atlas Lung Adenocarcinoma (TCGA-LUAD) dataset serves as a primary case study to demonstrate DRAFT's ability to reveal a dataset's potential to produce fragile, inequitable, and scientifically uninformative models, even when preliminary modeling achieves high performance metrics. This framework provides a necessary template for vetting datasets, ensuring that subsequent computational models built upon them are robust, equitable, and capable of generating true scientific insight. © 2025 Wiley Periodicals LLC.

Support Protocol 1: Environment and software installation via Conda

Support Protocol 2: TCGA-LUAD case study: Data acquisition and preparation

Basic Protocol 1: Generalization audit: Assessing for overfitting and illusory performance

Basic Protocol 2: Equity audit: Assessing for hidden stratification and algorithmic bias

Basic Protocol 3: Stability audit: Assessing for spurious discoveries and scientific utility

本协议详细介绍了训练数据集准备评估(DRAFT),这是一种确定高维生物数据集是否适合开发可靠和公平的机器学习模型的系统方法。标准模型验证通常无法检测到性能何时由数据集中的虚假相关性驱动,从而导致不可复制的发现。DRAFT提供了一个循序渐进的方法,在广泛建模开始之前对数据集的完整性进行多轴评估。评估包括三种基本方案来探测数据集的特征:(1)在严格的交叉验证下,通过测试基线模型的性能和稳定性来评估其泛化潜力;(2)通过分析人口统计亚组的模型性能和校准来审计固有偏差;(3)通过评估预测特征的稳定性来衡量其科学实用能力。癌症基因组图谱肺腺癌(TCGA-LUAD)数据集作为一个主要的案例研究,证明了DRAFT能够揭示数据集产生脆弱、不公平和缺乏科学信息的模型的潜力,即使初步建模达到了高性能指标。该框架为审查数据集提供了必要的模板,确保在此基础上建立的后续计算模型稳健、公平,并能够产生真正的科学见解。©2025 Wiley期刊有限责任公司支持协议1:通过Conda进行环境和软件安装支持协议2:TCGA-LUAD案例研究:数据采集和准备基本协议1:概括审计:评估过拟合和虚幻性能基本协议2:公平审计:评估隐藏分层和算法偏差基本协议3:稳定性审计:评估虚假发现和科学效用。
{"title":"Dataset Readiness Assessment for Training (DRAFT): A Protocol for Auditing High-Dimensional Biological Data","authors":"Guillaume Guerard,&nbsp;Sonia Djebali","doi":"10.1002/cpz1.70285","DOIUrl":"10.1002/cpz1.70285","url":null,"abstract":"<p>This protocol details Dataset Readiness Assessment for Training (DRAFT), a systematic method for determining if a high-dimensional biological dataset is suitable for developing reliable and equitable machine learning models. Standard model validation often fails to detect when performance is driven by spurious correlations within the dataset, leading to irreproducible findings. DRAFT provides a step-by-step methodology to perform a multiaxis assessment of a dataset's integrity before extensive modeling begins. The assessment comprises three basic protocols to probe the dataset's characteristics: (1) evaluating its potential for generalization by testing baseline model performance and stability under rigorous cross-validation; (2) auditing for inherent biases by analyzing model performance and calibration across demographic subgroups; and (3) measuring its capacity for scientific utility by assessing the stability of predictive features. The Cancer Genome Atlas Lung Adenocarcinoma (TCGA-LUAD) dataset serves as a primary case study to demonstrate DRAFT's ability to reveal a dataset's potential to produce fragile, inequitable, and scientifically uninformative models, even when preliminary modeling achieves high performance metrics. This framework provides a necessary template for vetting datasets, ensuring that subsequent computational models built upon them are robust, equitable, and capable of generating true scientific insight. © 2025 Wiley Periodicals LLC.</p><p><b>Support Protocol 1</b>: Environment and software installation via Conda</p><p><b>Support Protocol 2</b>: TCGA-LUAD case study: Data acquisition and preparation</p><p><b>Basic Protocol 1</b>: Generalization audit: Assessing for overfitting and illusory performance</p><p><b>Basic Protocol 2</b>: Equity audit: Assessing for hidden stratification and algorithmic bias</p><p><b>Basic Protocol 3</b>: Stability audit: Assessing for spurious discoveries and scientific utility</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover Image, Volume 5, Issue 12 封面图片,第5卷,第12期
IF 2.2 Pub Date : 2025-12-16 DOI: 10.1002/cpz1.70295

The cover image is based on the article Rice straw tissue preparation for reproducible electron microscopy imaging and analysis by Mahta Mohamadiaza et al., https://doi.org/10.1002/cpz1.70262.

封面图片是根据Mahta Mohamadiaza等人的文章《水稻秸秆组织制备的可重复电镜成像与分析》,https://doi.org/10.1002/cpz1.70262。
{"title":"Cover Image, Volume 5, Issue 12","authors":"","doi":"10.1002/cpz1.70295","DOIUrl":"https://doi.org/10.1002/cpz1.70295","url":null,"abstract":"<p>The cover image is based on the article <i>Rice straw tissue preparation for reproducible electron microscopy imaging and analysis</i> by Mahta Mohamadiaza et al., https://doi.org/10.1002/cpz1.70262.\u0000\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"5 12","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://currentprotocols.onlinelibrary.wiley.com/doi/epdf/10.1002/cpz1.70295","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145814561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current protocols
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1